A novel signaling cascade, IL-6/STAT3/HIF-1α, has been discovered in numerous cancer types including pancreatic cancer, prostate cancer, lung cancer, colon cancer, and malignant glioma [44, 45]. This evidence concerns the gene HIF1A and prostate cancer.